These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 7735442
21. Some risk factors for cerebral palsy in very premature infants: importance of premature rupture of membranes and monochorionic twin placentation. Burguet A, Monnet E, Pauchard JY, Roth P, Fromentin C, Dalphin ML, Allemand H, Maillet R, Menget A. Biol Neonate; 1999 Mar; 75(3):177-86. PubMed ID: 9925905 [Abstract] [Full Text] [Related]
22. Changes in neurodevelopmental outcome at age eight in geographic cohorts of children born at 22-27 weeks' gestational age during the 1990s. Roberts G, Anderson PJ, De Luca C, Doyle LW, Victorian Infant Collaborative Study Group. Arch Dis Child Fetal Neonatal Ed; 2010 Mar; 95(2):F90-4. PubMed ID: 19846389 [Abstract] [Full Text] [Related]
23. Before viability: a geographically based outcome study of infants weighing 500 grams or less at birth. Sauve RS, Robertson C, Etches P, Byrne PJ, Dayer-Zamora V. Pediatrics; 1998 Mar; 101(3 Pt 1):438-45. PubMed ID: 9481011 [Abstract] [Full Text] [Related]
29. Neurological handicaps among children whose mothers smoked during pregnancy. Rantakallio P, Koiranen M. Prev Med; 1987 Sep; 16(5):597-606. PubMed ID: 3684972 [Abstract] [Full Text] [Related]
30. Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2). Lorthe E, Torchin H, Delorme P, Ancel PY, Marchand-Martin L, Foix-L'Hélias L, Benhammou V, Gire C, d'Ercole C, Winer N, Sentilhes L, Subtil D, Goffinet F, Kayem G. Am J Obstet Gynecol; 2018 Sep; 219(3):298.e1-298.e14. PubMed ID: 29852153 [Abstract] [Full Text] [Related]
31. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, Ohlsson A, Barrington KJ, Roberts RS, Caffeine for Apnea of Prematurity (CAP) Trial Investigators. JAMA; 2012 Jan 18; 307(3):275-82. PubMed ID: 22253394 [Abstract] [Full Text] [Related]
32. Prevalence of cerebral palsy, intellectual disability, hearing loss, and blindness, National Health Interview Survey, 2009-2016. McGuire DO, Tian LH, Yeargin-Allsopp M, Dowling NF, Christensen DL. Disabil Health J; 2019 Jul 18; 12(3):443-451. PubMed ID: 30713095 [Abstract] [Full Text] [Related]
33. Risk factors for major neurodevelopmental impairments and need for special education resources in extremely premature infants. Msall ME, Buck GM, Rogers BT, Merke D, Catanzaro NL, Zorn WA. J Pediatr; 1991 Oct 18; 119(4):606-14. PubMed ID: 1919894 [Abstract] [Full Text] [Related]
35. Neurodevelopmental outcome of extremely premature infants exposed to incomplete, no or complete antenatal steroids. Chawla S, Bapat R, Pappas A, Bara R, Zidan M, Natarajan G. J Matern Fetal Neonatal Med; 2013 Oct 18; 26(15):1542-7. PubMed ID: 23565886 [Abstract] [Full Text] [Related]
40. Perinatal factors associated with the neurologic impairment of children born preterm. Skrablin S, Maurac I, Banović V, Bosnjak-Nadj K. Int J Gynaecol Obstet; 2008 Jul 07; 102(1):12-8. PubMed ID: 18387612 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]